{
  "ticker": "IPD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969733",
  "id": "02969733",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250716",
  "time": "0945",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lv6xr009kg3p.pdf",
  "summary": "### Key Material Information:  \n\n#### **Sales Update**:  \n- **Q4 FY25 US sales**: 44 units (+100% QoQ, +91% YoY).  \n- **Total Contract Value (TCV)**: Record A$6.3m, up 29% QoQ.  \n- **Notable contract**: 9-unit deal with **Legacy Health** (6-hospital system).  \n\n#### **Capital Growth Facility**:  \n- **Tranche 2 drawdown**: US$5m unlocked (total facility now US$15m).  \n- **Interest-only period extended**: From 24 to 36 months.  \n- **Use of funds**: Growth/commercialization activities, limiting equity dilution.  \n\n#### **Forward Outlook**:  \n- Targeting similar sales in **Q1 FY26**, with further pipeline conversion expected.  \n- Quarterly report (Appendix 4C) due **31 July 2025**.  \n\n*Omitted: Management commentary, operational details without direct financial/trading impact.*",
  "usage": {
    "prompt_tokens": 2221,
    "completion_tokens": 211,
    "total_tokens": 2432,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-15T23:56:50.348208"
}